Full Text View
Tabular View
No Study Results Posted
Related Studies
Study to Evaluate the Efficacy and Safety of OxabactTM on Reduction of Urinary Oxalate in Primary Hyperoxaluria Patients (PHOENIX)
This study has been completed.
Study NCT00638703   Information provided by OxThera

First Received on March 12, 2008.   Last Updated on May 7, 2013   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Primary Hyperoxaluria
Additional conditions recognized in this trial
Hyperoxaluria
Hyperoxaluria, Primary
More general conditions related to this trial
Carbohydrate Metabolism, Inborn Errors
Genetic Diseases, Inborn
Kidney Diseases
Metabolic Diseases
Metabolism, Inborn Errors
Urologic Diseases
Interventions listed in this trial
Oxalobacter formigenes
Placebo
Sponsors listed in this trial
OxThera


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services